VVM
Versant Venture Management’s Adverum Biotechnologies ADVM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.09M | Hold |
506,821
| – | – | 1.33% | 8 |
|
|
2025
Q1 | $2.21M | Hold |
506,821
| – | – | 3.68% | 7 |
|
|
2024
Q4 | $2.37M | Hold |
506,821
| – | – | 2.73% | 7 |
|
|
2024
Q3 | $3.56M | Hold |
506,821
| – | – | 5.6% | 5 |
|
|
2024
Q2 | $3.48M | Sell |
506,821
-1
| -0% | -$7 | 4.5% | 5 |
|
|
2024
Q1 | $7.17M | Sell |
506,822
-4,561,411
| -90% | -$64.5M | 6.95% | 5 |
|
|
2023
Q4 | $3.82M | Hold |
5,068,233
| – | – | 0.98% | 6 |
|
|
2023
Q3 | $7.6M | Hold |
5,068,233
| – | – | 4.04% | 4 |
|
|
2023
Q2 | $8.06M | Hold |
5,068,233
| – | – | 9.56% | 3 |
|
|
2023
Q1 | $3.64M | Hold |
5,068,233
| – | – | 7.58% | 5 |
|
|
2022
Q4 | $2.94M | Hold |
5,068,233
| – | – | 6.08% | 5 |
|
|
2022
Q3 | $4.82M | Hold |
5,068,233
| – | – | 8.21% | 4 |
|
|
2022
Q2 | $6.08M | Hold |
5,068,233
| – | – | 9.32% | 4 |
|
|
2022
Q1 | $6.64M | Hold |
5,068,233
| – | – | 6.63% | 7 |
|
|
2021
Q4 | $8.92M | Hold |
5,068,233
| – | – | 4.77% | 7 |
|
|
2021
Q3 | $11M | Hold |
5,068,233
| – | – | 4.55% | 7 |
|
|
2021
Q2 | $17.7M | Hold |
5,068,233
| – | – | 5.88% | 5 |
|
|
2021
Q1 | $50M | Buy |
5,068,233
+64,341
| +1% | +$634K | 9.74% | 4 |
|
|
2020
Q4 | $54.2M | Sell |
5,003,892
-2,000,000
| -29% | -$21.7M | 5.63% | 4 |
|
|
2020
Q3 | $72.1M | Hold |
7,003,892
| – | – | 13.2% | 2 |
|
|
2020
Q2 | $146M | Sell |
7,003,892
-64,341
| -0.9% | -$1.34M | 21.01% | 2 |
|
|
2020
Q1 | $69.1M | Buy |
+7,068,233
| New | +$69.1M | 18.94% | 2 |
|